Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Dec 30;6(4):313–320. doi: 10.5114/ceh.2020.102169

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © 2020 Clinical and Experimental Hepatology

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

PMC Copyright notice

Fig. 3 — An 80-year-old man with chronic hepatitis C and raised AFP (845 ng/ml), Child-Pugh class A6, MELD score of 9 and BCLC stage C. Axial MRI T1 FS images demonstrate a rounded HCC (yellow arrows) of segment V, showing hyposignal on the non-enhanced image (A), with homogeneous wash-in at arterial phase compared to adjacent normal liver (B) and wash-out on portal venous phase (C). Note the enhancing capsule (arrow-head) in portal venous phase (C). The HCC size is about 38 mm. DSA images demonstrate tumoral blush (arrow-heads) (D, E). Note the total extinction of tumoral blush after Lipiodol-doxorubicin injection (arrow-heads) (F)